Genomic Health Newswire (Page 4)

Genomic Health Newswire (Page 4)

Comprehensive Real-Time News Feed for Genomic Health. (Page 4)

Results 61 - 80 of 779 in Genomic Health

  1. Global Companion Diagnostic Tests in Oncology Market Industry Analysis, Trends and ForecastRead the original story w/Photo

    Jun 26, 2017 | SBWire

    ... Oncology market such as F. Hoffman LA Roche Ltd., QIAGEN, Illumina, Inc., Abbott, Agilent Technologies, Inc., Genomic Health, Inc., bioMerieux SA, BioGenex, AGENDIA NV,

    Comment?

  2. Genomic Health (GHDX) Getting Positive News Coverage, Study FindsRead the original story w/Photo

    Jun 24, 2017 | IntersportsWire

    Media coverage about Genomic Health has been trending positive on Saturday, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time.

    Comment?

  3. Mitsubishi UFJ Trust & Banking Corp Sells 5,160 Shares of Genomic Health, Inc.Read the original story w/Photo

    Jun 22, 2017 | IntersportsWire

    Mitsubishi UFJ Trust & Banking Corp reduced its position in Genomic Health, Inc. by 3.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 128,200 shares of the medical research company's stock after selling 5,160 shares during the period.

    Comment?

  4. Zacks: Brokerages Expect Genomic Health, Inc. (GHDX) Will Announce Quarterly Sales of $86.09 MillionRead the original story w/Photo

    Jun 22, 2017 | AmericanBankingNews.com

    Equities research analysts expect Genomic Health, Inc. to post sales of $86.09 million for the current quarter, Zacks reports. Six analysts have made estimates for Genomic Health's earnings, with the highest sales estimate coming in at $86.44 million and the lowest estimate coming in at $86.00 million.

    Comment?

  5. Zacks: Brokerages Expect Genomic Health, Inc. (GHDX) Will Announce Earnings of -$0.06 Per ShareRead the original story w/Photo

    Jun 20, 2017 | AmericanBankingNews.com

    Wall Street brokerages expect that Genomic Health, Inc. will report earnings per share of for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Genomic Health's earnings.

    Comment?

  6. Positive Press Coverage Somewhat Unlikely to Affect Genomic Health (GHDX) Stock PriceRead the original story w/Photo

    Jun 19, 2017 | IntersportsWire

    Media stories about Genomic Health have been trending positive on Monday, Alpha One Sentiment reports. The research firm, a unit of Accern, identifies positive and negative news coverage by reviewing more than twenty million news and blog sources.

    Comment?

  7. Genomic Health, Inc. (GHDX) Insider Steven Shak Sells 5,000 SharesRead the original story w/Photo

    Jun 17, 2017 | IntersportsWire

    Genomic Health, Inc. insider Steven Shak sold 5,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $29.40, for a total transaction of $147,000.00.

    Comment?

  8. Q3 2017 EPS Estimates for Genomic Health, Inc. Cut by AnalystRead the original story w/Photo

    Jun 16, 2017 | IntersportsWire

    Genomic Health, Inc. - Analysts at William Blair reduced their Q3 2017 EPS estimates for Genomic Health in a research note issued to investors on Wednesday. William Blair analyst A. Murphy now anticipates that the medical research company will post earnings per share of $0.02 for the quarter, down from their previous forecast of $0.03.

    Comment?

  9. Analysts Set Genomic Health, Inc. (GHDX) Target Price at $31.83Read the original story w/Photo

    Jun 15, 2017 | Daily Political

    Genomic Health, Inc. has been assigned a consensus rating of "Hold" from the ten research firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating on the company.

    Comment?

  10. Q3 2017 EPS Estimates for Genomic Health, Inc. Cut by AnalystRead the original story w/Photo

    Jun 12, 2017 | IntersportsWire

    Genomic Health, Inc. - Analysts at William Blair reduced their Q3 2017 EPS estimates for Genomic Health in a research note issued to investors on Wednesday. William Blair analyst A. Murphy now anticipates that the medical research company will post earnings per share of $0.02 for the quarter, down from their previous forecast of $0.03.

    Comment?

  11. Genomic Health, Inc. (GHDX) Receives Hold Rating from Jefferies Group LLCRead the original story w/Photo

    Jun 12, 2017 | AmericanBankingNews.com

    ... price. GHDX has been the subject of several other reports. Zacks Investment Research downgraded shares of Genomic Health from a "hold" rating to a "strong sell" rating in a research report on Tuesday, April 18th. TheStreet raised shares of Genomic ...

    Comment?

  12. Mitsubishi UFJ Trust & Banking Corp Has $4.04 Million Position in Genomic Health, Inc.Read the original story w/Photo

    Jun 10, 2017 | IntersportsWire

    Mitsubishi UFJ Trust & Banking Corp decreased its position in Genomic Health, Inc. by 3.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 128,200 shares of the medical research company's stock after selling 5,160 shares during the period.

    Comment?

  13. Genomic Health, Inc. (GHDX) Issues Earnings ResultsRead the original story w/Photo

    Jun 10, 2017 | IntersportsWire

    Genomic Health, Inc. announced its earnings results on Tuesday, May 9th. The medical research company reported earnings per share for the quarter, missing the Zacks' consensus estimate of by $0.01, Morningstar.com reports.

    Comment?

  14. Genomic Health, Inc. (GHDX) Insider Sells $158,850.00 in StockRead the original story w/Photo

    Jun 8, 2017 | IntersportsWire

    Genomic Health, Inc. insider Kimberly J. Popovits sold 5,000 shares of Genomic Health stock in a transaction dated Wednesday, May 3rd. The shares were sold at an average price of $31.77, for a total transaction of $158,850.00.

    Comment?

  15. Genomic Health: New Data Show Important Role Of Genomic Testing In...Read the original story

    Jun 5, 2017 | BioSpace

    Genomic Health announced results from an analysis of patients with hormone-receptor-positive , early-stage breast cancer at the American Society for Clinical Oncology annual meeting , June 2 - 6, in Chicago, Illinois. New data show that using the Oncotype DX Breast Recurrence ScoreA test to identify the right patients to treat with chemotherapy, can benefit patients 70 years or greater, similar to the outcomes reported for younger patients.

    Comment?

  16. Genomic Health, Inc. (GHDX) Insider Steven Shak Sells 5,000 SharesRead the original story w/Photo

    Jun 4, 2017 | IntersportsWire

    Genomic Health, Inc. insider Steven Shak sold 5,000 shares of Genomic Health stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $29.40, for a total value of $147,000.00.

    Comment?

  17. Genomic Health (GHDX) Earning Positive News Coverage, Report ShowsRead the original story w/Photo

    Jun 4, 2017 | IntersportsWire

    News articles about Genomic Health have trended positive on Sunday, according to Alpha One Sentiment. The research firm, a unit of Accern, scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time.

    Comment?

  18. Genomic Health Inc (GHDX) - Product Pipeline Analysis: Size, Share, Growth, Trends and ForecastRead the original story

    Jun 3, 2017 | Emailwire.com

    The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication , application and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

    Comment?

  19. Genomic Health Presents Data Further Demonstrating Ability of...Read the original story

    Jun 2, 2017 | PressReleasePoint

    Genomic Health, Inc. today announced the presentation of eight studies that provide additional evidence of the value of Oncotype DXA tests in predicting clinically meaningful endpoints and outcomes across multiple cancer types. The data from patients with invasive breast, ductal carcinoma in situ , prostate and kidney cancers were presented in oral and poster sessions at the 2017 American Society of Clinical Oncology Annual Meeting in Chicago.

    Comment?

  20. Brokers Offer Predictions for Genomic Health, Inc.'s Q2 2017 EarningsRead the original story w/Photo

    Jun 2, 2017 | IntersportsWire

    Genomic Health, Inc. - Investment analysts at William Blair dropped their Q2 2017 earnings estimates for shares of Genomic Health in a report released on Wednesday. William Blair analyst A. Murphy now expects that the medical research company will post earnings of per share for the quarter, down from their previous forecast of .

    Comment?